Abhay Bhatt, MD
Professor
Department:
SOM-Peds-Neonatology
Email:
abhatt@umc.edu
Work Phone:
(601) 815-7100
Biography
Dr. Abhay Bhatt is a Professor of Pediatrics and Director of Research in the division of newborn medicine and the department of Pediatrics at UMMC. His primary research interests are hypoxic-ischemic (HI), oxygen, inflammation, and steroid-induced injury to the developing brain. His long-term research goals are to understand how to target molecular mechanisms causing ongoing brain damage following these insults in order to develop improved strategies for the prevention and treatment of brain injury in newborn infants and to develop corticosteroids regimens for the treatment of chronic lung disease of prematurity and vasopressor-resistant hypotension without any major toxicity, particularly neurotoxicity. As director of Research, Dr. Bhatt looks forward to continuing to sustain and expand discovery in the division and thus achieving the vision of Children’s Mississippi to touch the life of every child in Mississippi and help them reach their full potential. As a neonatologist, Dr. Bhatt supports the mission of the newborn division to achieve the highest standards of performance to provide support for critically ill and preterm newborn infants and their families through compassionate clinical care. He also supervises quality improvement projects in the NICU. Dr. Bhatt has a keen interest in educational activities to develop outstanding health care professionals.
Education
| Millsaps College, Jackson, MS, Certificate of Completion, Business Advantage Program | 2013 |
| University of Rochester, Children’s Hospital at Strong, Rochester, NY, MD, Neonatal-Perinatal Medicine | 1999 |
| Children’s Medical Center at Brooklyn, State University of New York, New York, NY, MD, Pediatrics | 1996 |
| Gujarat University, Sheth K.M. School of P.G. Medicine & Research, Ahmedabad, India, MD, Pediatrics | 1992 |
| Gujarat University, Smt. N. H. L. M. Medical College, Ahmedabad, India, MBBS, Medicine | 1989 |
Specialty Certification Licensure
| Certification, Diplomate in Neonatal-Perinatal Medicine, The American Board of Pediatrics | 10/1999 - Present |
| Certification, Neonatal Resuscitation Program (NRP) Provider | 06/2015 |
| Licensure, Mississippi State Board of Medical Licensure | 07/2012 - 06/2015 |
| Certification, Diplomate of The American Board of Pediatrics, The American Board of Pediatrics | 10/1996 - 12/2013 |
| Licensure, Mississippi State Medical Board | 03/2000 - 06/2012 |
Current Positions
| Physician Liaison/Medical Director, NICU at MHG, School of Medicine | 01/2018 - Present |
| Director of Research, Newborn Division, School of Medicine, Department of Pediatrics | 11/2016 - Present |
| Professor, School of Medicine, Department of Pediatrics | 07/2015 - Present |
| Team Leader VON Database, School of Medicine | 2012 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Clinical Science Director of CDDR, Center for Developmental Disorders Research (CDDR), School of Medicine | 05/2014 - 10/2017 |
| Vice Chair, University of Mississippi Medical Center, Jackson, MS, School of Medicine, Department of Pediatrics | 2014 - 10/2016 |
| Interim Chief, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 07/2012 - 03/2013 |
| Associate Professor, University Of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 07/2010 - 06/2015 |
| Medical Director, Newborn Intensive Care Unit, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 2009 - 12/2013 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 2006 - 06/2010 |
| Consultant Neonatologist, Ahmedabad, India | 2004 - 12/2005 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 04/2000 - 09/2003 |
Sponsored Program Funding
| Extramural, A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY), Medlmmune, Inc | 08/2019 - Present |
| Extramural, D5290C00004- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half- Life Against Respiratory Syncytial Virus, In Healthy Late Preterm and Term Infants (MELODY), Medlmmune, Inc | 08/2019 - Present |
| Extramural, A Phase 2b, Multicenter, Randomized, Open-Label, Controlled, 3-Arm Study to Evaluate the Clinical Efficacy and Safety of SHP607 in Preventing Chronic Lung Disease Through 12 Months Corrected Age Compared to Standard Neonatal Care in Extremely Premature Infants, Shire | 03/2019 - Present |
| Extramural, Multicenter, Prospectively Defined Observational Registry with Retrospective Data Collection, Evaluating Premature and Term-Near-Term Neonates with Pulmonary Hypertension Receiving Inhaled Nitric Oxide via Invasive or Noninvasive Ventilator Support at US Centers., Mallinckrodt Pharmaceuticals, Inc | 04/2018 - 08/2020 |
| Extramural, Medical Optimization & Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD)., NICHD | 03/2018 - Present |
| Extramural, A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants., Medlmmune, Inc | 09/2017 - 03/2019 |
| Extramural, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants., Regeneron Pharmaceuticals. Inc. | 06/2017 - 06/2018 |
| Extramural, Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity. A Phase 2, Randomized Controlled, Assessor-blind, Dose-confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study, Shire Human Genetic Therapies, Inc | 09/2015 - 07/2016 |
Publications
United States Patent Application | |
| Fan LW, Bhatt AJ Serial No.: 16/891,789: COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING OR REDUCING HYPOXIA-ISCHEMIA INDUCED BRAIN DAMAGE AND NEUROBEHAVIORAL DYSFUNCTION IN NEONATES | 2020 |
Journal Article | |
| Feng Y, Famuyide M, Bhatt AJ Dexamethasone decreases insulin-like growth factor-I and -II via a glucocorticoid receptor dependent mechanism in developing rat brain. Neuro Endocrinol Lett. 2013;34(7):624-34 | 2013 |
Abstracts | |
| Dankhara N*, Lee JW, Ojeda N, Lu S, White E, Xu S, C Glendye C, Pang Y, Bhatt AJ and Fan L *SSPR Basic Science Young Investigator Award Finalist INTRANASAL INSULIN AND SEX-SPECIFIC EFFECTS ON LONG-TERM NEUROBEHAVIORAL OUTCOMES FOLLOWING HYPOXIC-ISCHEMIC BRAIN INJURY IN NEONATAL RATS. SSPR 2021, Abstract 117 | 2021 |
| Desai J, Famuyide M, Patel J, Kalikkot R, Bhatt A. Gender and Racial Disparities of Pulmonary Interstitial Emphysema among Preterm Infants: An Analysis of the National Kids' Inpatient Database. Pediatric Academic Societies 2017, San Francisco, CA, May 2017. | 2017 |
| Desai J, Savich R, Patel J, Kalikkot R, Bhatt A. Significant Decrease in Critical Congenital Heart Disease in the Neonatal Period Presenting in the Emergency Department After Implementation of CCHD Screening: Analysis of a National Database. Pediatric Academic Societies 2017, San Francisco, CA, May 2017. | 2017 |
| Narang R, Carter K, Muncie CB, Pang Y, Fan L-W, Feng Y, Ojeda N, Bhatt AJ. Novel model of hypoxic-ischemic brain damage in intra uterine growth restricted newborn rats. Southern Society for Pediatric Research, New Orleans, LA, February 2017. | 2017 |
| Ramarao S, Pang Y, Carater K. Bhatt A. Macrolides Suppress LPS Induced Inflammatory In vitro Brain Injury Mediated by Microglia. Southern Society for Pediatric Research, New Orleans, LA, February 2017. | 2017 |
| Fan L-W, Tien L-T,Lee JW, Lu S,Lin RCS, Dai X, Bhatt AJ,Pang Y. Neonatal Exposure to interleukin-1beta enhances adult vulnerability to rotenone neurotoxicity. The 46th Annual Meeting of the Society for Neuroscience, San Diego, CA, November 2016. | 2016 |
| Bhatt AJ, Fan LW, Dai X, Pang Y Combined treatment of lipopolysaccharide and hyperoxia leads to enhanced neurodevelopment disturbances in neonatal rats. EPAS | 2015 |
| Bhatt AJ, Feng Y, Kumar P. Hydrocortisone Pre-treatment Reduces Hypoxic Ischemic Brain Injury in Neonatal Rats. E-PAS2014: 4118.299 | 2014 |
| Pang Y Bhatt A, Fan LW, Dai X, Tien LT, Kumar P. The role of microglia in myelination: A friend or a foe. E-PAS2014. 3375.8 | 2014 |
| Fan LW, Tien LT, Zhu H, Bhatt AJ, Kumar P, Pang Y Interleukin-1 receptor antagonist attenuates neonatal lipopolysaccharide-enhanced adult susceptibility to the neurodegenerative disorder induced by rotenone. E-PAS2014. 1546.661 | 2014 |
| Bhatt AJ, Feng Y, Kumar P. Hydrocortisone Pre-treatment Reduces Hypoxic Ischemic Brain Injury in Neonatal Rats. Journal of Investigative Medicine • Volume 62, Number 2, February 2014. A 445 | 2014 |
| Pang Y, Tien LT, Zheng B, Bhatt AJ, LIn RCS, Fan LW Do microglia play a role in myelination during development? Soc. Neurosci Abstr. The 43rd Annual Meeting of The Society for Neuroscience, San Diego, CA, Nov.9-13, 2013. | 2013 |
| Fan LW, Tien LT, Cai Z, Bhatt AJ, Pang Y Intranasal administration of insulin-like growth factor-1 ameliorates dopaminergic neuronal injury and improves motor behavioral performance in juvenile rats following neonatal exposure to liopoplysaccharide Soc. Neurosci Abstr. The 43rd Annual Meeting of The Society for Neuroscience, San Diego, CA, Nov. 9-13, 2013. | 2013 |
| Bhatt AJ, Feng Y, J Wang, M Famuyide Insulin Like Growth Factor- I Fails To Protect Against Dexamethasone-Induced Neurodegeneration In Neonatal Rats E-PAS2013: 1539.544 | 2013 |
| Feng Y, M Famuyide, Bhatt AJ Glucocorticoid Receptor Blocker Attenuates The Dexamethasone Induced Decrease of Insulin-Like Growth Factor-I and -II in Neonatal Rat Brain Presented at the 42nd International Neuroscience Conference, October 2012, New Orleans, LA | 2012 |
| Bhatt AJ, Feng Y, J Wang, M Famuyide Dexamethasone but Not Hydrocortisone Decreases Neurogenesis in Neonatal Rats Presented at the 42nd International Neuroscience Conference, October 2012, New Orleans, LA | 2012 |
| Bhatt AJ, Feng Y, Rhodes PG Dexamethasone but not hydrocortisone decreases proliferating cells in neonatal rat brains E-PAS2012: 1526.437 | 2012 |
| Feng Y, Rhodes PG, J Wang, Bhatt AJ Dexamethasone but not hydrocortisone induces apoptosis in neonatal brain and impairs learning and memory function in later life Presented at the 41th International Neuroscience Conference, November 2011, Washington DC | 2011 |
| Feng Y, Rhodes PG, Bhatt AJ Dexamethasone induced neuroprotection is mediated in part via Akt activation in yypoxic−ischemic brain injury in newborn rats E-PAS2011: 4533.478 | 2011 |
| Bhatt AJ, Feng Y, Rhodes PG Hydrocortisone is safer than dexamethasone and provides similar neuroprotection against subsequent hypoxic−ischemic brain injury in neonatal rats E-PAS2011: 4533.479 | 2011 |
| Feng Y, Rhodes PG, Bhatt AJ Pituitary adrenal axis adaptation following hypoxic preconditioning provides neuroprotection against subsequent hypoxic-ischemic brain injury in newborn rats International Neuroscience Conference, November 2010, San Diego, CA | 2010 |
| Bhatt AJ, Feng Y, Rhodes PG Dexamethasone but not the equivalent doses of hydrocortisone induces apoptosis and neurodegeneration in neonatal rat brain Presented at the 40th International Neuroscience Conference, November 2010, San Diego, CA, Program No. 727.7 | 2010 |
| Feng Y, Rhodes PG, Bhatt AJ Corticosteroid responses following hypoxic preconditioning provide neuroprotection against subsequent hypoxic-ischemic brain injury in newborn rats E-PAS2010: 3744.463 | 2010 |
| Bhatt AJ, Feng Y, Rhodes PG Dexamethasone induces apoptosis and neurodegeneration in neonatal rat brain E-PAS2010: 3744.479 | 2010 |
| Feng Y, Rhodes PG, Bhatt AJ Dexamethasone induces apoptosis and neurodegeneration in neonatal rat brain Presented at the 39th International Neuroscience Conference, October 2009, Chicago, IL | 2009 |
| Bhatt AJ, Feng Y, Rhodes PG Dexamethasone decreases Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-II in the neonatal rat brain E-PAS2009: 3871.329 | 2009 |
| Feng Y, Rhodes PG, Bhatt AJ Dexamethasone enhances up-regulation of vascular endothelial growth factor A mRNA expression after hypoxic-ischemic brain injury in neonatal rats Presented at the 38th International Neuroscience Conference, November 2008, Washington DC, Program No. 749.8 | 2008 |
| Feng Y, Rhodes PG, Bhatt AJ Dexamethasone Increase Nerve Growth Factor (NGF) and Vascular Endothelial Growth Factor A (VEGF) mRNA Expression in the Neonatal Rat Brain E-PAS2008: 5828.18 | 2008 |
| Bhatt AJ, Feng Y, Rhodes PG Hypoxic Preconditioning Augments and Preserves the Increase in the mRNA Expression of VEGF Isoforms by Hypoxia-Ischemia in Newborn Rat Brain E-PAS2008: 5828.36 | 2008 |
| Feng Y, Rhodes PG, Bhatt AJ Dexamethasone increases total vascular endothelial growth factor A but decreases vascular endothelial growth factor A164 in neonatal rat brain Presented at the 37th International Neuroscience Conference, November 2007, San Diego, CA, Program No. 456.19 | 2007 |
| Bhatt AJ, Feng Y, Rhodes PG Neuroprotective Effects of Vascular Endothelial Growth Factor A (VEGF A) following Hypoxic ischemic Brain Injury in Neonatal Rats E-PAS2007: 7350.3 | 2007 |
| Bhatt AJ, Hutchins JM, Rhodes PG Hypoxia-Ischemia (HI) Increases Hypoxia-Inducible Factor-1a (HIF-1a) and Vascular Growth Factors (VEGF) in Developing Rat Brain Pediatric Research, 2003; 53, #4, Abstract #1971, 346A | 2003 |
| Amin SB, Bhatt AJ, Maniscalco WM In-situ antibiotic therapy for confirmed percutaneous central venous catheter (PSC) infections in neonates Pediatric Research, 2001; 49: Abstract #1329 | 2001 |
| Bhatt AJ, Watkins RH, Huyck H, Maniscalco WM Decreased Vascular Endothelial Growth Factor (VEGF), VEGF receptor (flt-1) and endothelial marker, PECAM, in premature baboons with chronic lung disease (CLD) American Journal of Respiratory and Critical Care Medicine, May 2000 | 2000 |
| Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Maniscalco WM Evidence for Disrupted Microvascular Development in Premature Human Infants Dying with bronchopulmonarydysplasia (BPD) American Journal of Respiratory and Critical Care Medicine, May 2000 | 2000 |
| Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Maniscalco WM Vascular dysmorphic changes in premature human infants dying with bronchopulmonarydysplasia Journal of Investigative Medicine, March 2000. 48, #2, Abstract # 169 | 2000 |
| Bhatt AJ, Watkins RH, Chess PR, Maniscalco WM Dexamethasone induces vascular endothelial growth factor (VEGF) and hypoxia inducible factor-like factor (HLF) mRNA abundance in postnatal mice American Journal of Respiratory and Critical Care Medicine Journal, March 1999; 159:3, A900 | 1999 |
| Bhatt AJ, Watkins RH, Chess PR, Maniscalco WM Vascular Endothelial Growth Factor (VEGF), VEGF Receptor (fLK-1) and Hypoxia Inducible factor-like factor (HLF) mRNA Abundance are Increased by Dexamethasone in Postnatal Mouse Lung Pediatric Research, 1999; 45:48A, Abstract #275 | 1999 |
| Talati C*, Lee JW, Lu S, Nielson T, Raval R, Prakash V, Ojeda N, Pang Y, Bhatt AJ and Fan L *SSPR BASIC SCIENCE YOUNG INVESTIGATOR AWARD Winner REDUCTION OF HYPOXIA-ISCHEMIA INDUCED EARLY BRAIN DAMAGEAND SENSORIMOTOR BEHAVIORAL DISTURBANCES BY INTRANASAL INSULIN TREATMENT IN NEONATAL RATS. J Clin Investi, 2019, Abstract 551 | |
| Ojeda NB, Intapad S, Carter AJ, Alexander BT, Bhatt A. Developmental origins of renal diseases: a translational approach. FASEB J. 2013;27:A919.1 | |
Book Chapter | |
| Bhatt AJ, Ryan RM Pulmonary Interstitial Emphysema. Medscape Reference. Updated October 09, 2013. | 2013 |
| Bhatt AJ, Ryan RM Pulmonary Interstitial Emphysema EMedicine, 3 (5): topic 2596, 2002 | 2002 |
Presentations
| Platform Presentations, INTRAPERITONEAL LIPOPOLYSACCHARIDE DISRUPTS EARLY NEURAL DEVELOPMENTAL PROGRAMS AND IMPAIRS BEHAVIORS IN NEONATAL RATS, Southern Society for Pediatric Research, New Orleans, Louisiana | 02/2016 |
| Platform Presentations, COMBINED EFFECTS OF LIPOPOLYSACCHARIDE AND HYPEROXIA LEADS TO ENHANCED NEURODEVELOPMENTAL DISTURBANCES IN NEONATAL RATS, Southern Society for Pediatric Research, New Orleans, Louisiana | 02/2015 |
| Scientific Presentations, Hydrocortisone Pre-treatment Reduces Hypoxic Ischemic Brain Injury in Neonatal Rats, Southern Society for Pediatric Research, New Orleans, LA | 02/2014 |
| Poster Presentation, Insulin Like Growth Factor- I Fails To Protect Against Dexamethasone-Induced Neurodegeneration In Neonatal Rats, Pediatric Academic Societies- Society for Pediatric Research Annual Meeting, Washington, DC | 05/2013 |
| Scientific Presentations, Insulin-like growth factor-1 fails to protect against dexamethasone-induced neurodegeneration in neonatal rats., Southern Society for Pediatric Research, New Orleans, LA | 02/2013 |
| Scientific Presentations, Dexamethasone but Not Hydrocortisone Decreases Neurogenesis in Neonatal Rats, International Neuroscience Conference, San Diego, CA | 10/2012 |
| Scientific Presentations, Glucocorticoid Receptor Blocker Attenuates The Dexamethasone Induced Decrease of Insulin-Like Growth Factor-I and -II in Neonatal Rat Brain, International Neuroscience Conference, San Diego, CA | 10/2012 |
| Poster Presentation, Dexamethasone but Not Hydrocortisone Decreases Proliferating Cells in Neonatal Rat Brains, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Boston, MA | 04/2012 |
| Platform Presentations, Dexamethasone but Not Hydrocortisone Decreases Proliferating Cells in Neonatal Rat Brains, Southern Society for Pediatric Research Annual Meeting, New Orleans, LA | 02/2012 |
| Scientific Presentations, Dexamethasone induced neuroprotection is mediated in part via Akt activation in hypoxic-ischemic brain injury in newborn rats, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Denver, CO | 05/2011 |
| Poster Presentation, Hydrocortisone is a safer than dexamethasone and provides similar neuroprotection against subsequent hypoxic-ischemic brain injury in neonatal rats, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Denver, CO | 05/2011 |
| Scientific Presentations, Differences in the apoptotic neurodegenerative effects of different glucocorticoids on developing rat brain, Southern Society of Pediatric Research Annual Conference, New Orleans, LA | 02/2011 |
| Scientific Presentations, Dexamethasone but not the equivalent doses of hydrocortisone induces apoptosis and neurodegeneration in neonatal rat brain, International Neuroscience Conference, San Diego, CA | 11/2010 |
| Scientific Presentations, Pituitary Adrenal Axis Adaptation Following Hypoxic Preconditioning provides Neuroprotection Against Subsequent Hypoxic-Ischemic Brain Injury In Newborn Rats, International Neuroscience Conference, San Diego, CA | 11/2010 |
| State/Local Invited Seminars/Lectures, Quality Improvement Measures-Critical Exercise or Waste of Time?, Neonatal Group Meeting | 09/2010 |
| Pediatric Grand Rounds, Quality Improvement Measures- Critical Exercise or Waste of time?, UMMC | 08/2010 |
| Poster Presentation, Dexamethasone Induces Apoptosis And Neurodegeneration In Neonatal Rat Brain., Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Vancouver, Canada | 05/2010 |
| Poster Presentation, Corticosteroid Responses Following Hypoxic Preconditioning Provide Neuroprotection Against Subsequent Hypoxic-Ischemic Brain Injury in Newborn Rats, Southern Society of Pediatric Research Annual Conference, New Orleans, LA | 02/2010 |
| Poster Presentation, Dexamethasone Decreases Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-II in the Neonatal Rat Brain, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Baltimore, Maryland | 05/2009 |
| Scientific Presentations, Dexamethasone Decreases Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-II in the Neonatal Rat Brain, Southern Society of Pediatric Research Annual Conference, New Orleans, LA | 02/2009 |
| Poster Presentation, Hypoxic Preconditioning Augments and Preserves the Increase in the mRNA Expression of VEGF Isoforms by Hypoxia-Ischemia in Newborn Rat Brain, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Honolulu, Hawaii | 05/2008 |
| Platform Presentations, Neuroprotective Effects of Vascular Endothelial Growth Factor A (VEGF A) Following Hypoxic Ischemic Brain Injury in Neonatal Rats, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Toronto, Canada | 05/2007 |
| Scientific Presentations, Hypoxia-Ischemia (HI) Increases Hypoxia-Inducible Factor 1α (HIF-1α) in Developing Rat Brain, International Neuroscience Conference, New Orleans, LA | 11/2003 |
| Poster Presentation, Hypoxia-Ischemia (HI) Increases Hypoxia-Inducible Factor-1α (HIF-1α) and Vascular Growth Factor (VEGF) in Developing Rat Brain., Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, Seattle, Washington | 05/2003 |
| Poster Presentation, Decreased Vascular Endothelial Growth Factor (VEGF), VEGF receptor (Flt-1) and Endothelial Marker, PECAM, in Premature Baboons with Chronic Lung Disease (CLD), American Thoracic Society International Conference, Toronto, Canada | 05/2000 |
| Poster Presentation, Evidence for Disrupted Microvascular Development in Premature Human Infants Dying with Bronchopulmonary Dysplasia (BPD), American Thoracic Society International Conference, Toronto, Canada | 05/2000 |
| Platform Presentations, Vascular Dysmorphic Changes in Premature Human Infants Dying with Bronchopulmonary Dysplasia., Easter Society of Pediatric Research Annual Conference, Atlantic City, NJ | 03/2000 |
| Poster Presentation, Vascular Endothelial Growth Factor (VEGF), VEGF Receptor (FLK-1) and Hypoxia Inducible Factor - Like Factor (HLF) mRNA Abundance are Increased by Dexamethasone in Postnatal Mouse Lung, Pediatric Academic Societies - Society for Pediatric Research Annual Meeting, San Francisco, CA | 05/1999 |
| Scientific Presentations, Dexamethasone Induces Vascular Endothelial Growth Factor (VEGF) and Hypoxia Inducible Factor - Like Factor (HLF) mRNA Abundance in Postnatal Mice., American Thoracic Society International Conference, San Diego, CA | 04/1999 |
Honors, Awards, and Recognition
| UMMC GWIMS Trailbazer Award, UMMC Group on Woman in Medicine and Science | 2018 |
| Intramural Funding- Hyperoxia, inflammation and cerebral white matter injury. Role: consultant, IRSP | 2014 |
Professional Membership and Service
| Southern Society for Pediatric Research, Member | |
| Society Of Pediatric Research, Member |
Committee Service
| Pedaitric Discovery Council, Member | 2016 - Present |
| Newborn Division P2 (Policy and Product Review) Committee, Member | 2013 - Present |
| Pediatric Discovery Council, Vice Chair | 2013 - 2016 |
| Newborn Division Performance Improvement Committee, Member | 2013 - Present |
| Neonatal-Perinatal Fellowship Planning Committee, Member | 2012 - Present |
| Children's Heart Center Advisory Board, Member | 2012 - 2013 |
| Pediatric Research Committee, Member | 2006 - 2013 |
Other Service
| Research, Member, Internal Advisory Committee, Mississippi Center of Excellence in Perinatal Research, Member, Internal Advisory Committee, Mississippi Center of Excellence in Perinatal Research | 08/2017 - Present |
| Quality Improvement Project: Nosocomial Infection Prevention Task Force at the Newborn Center of Children’s of Mississippi, Organized the task force, Developed Vision and Goals, Member | 08/2014 - 05/2015 |
| Quality Improvement Project: Golden Hour PI Team, Member | 05/2014 - Present |
| Quality Improvement Project: NICU Surfactant Administration PI Team, Lead Role | 2013 - 05/2014 |
| Quality Improvement Project: NICU Temperature PI Team, Lead Role | 2013 - 05/2014 |
| In-Charge Newborn Division Attending Scheduling | 2012 - Present |
| Quality Improvement Project: NICU Infection Prevention Team, Lead Role | 07/2009 - 07/2014 |
Teaching Experience
| Medicine, Course Director, Pediatric Discovery Seminar | - 2016 |
| Medicine, Lecture, Course Director, Newborn Research Conference | |
| Medicine, Small Group, Facilitator, Newborn Lab Research Monthly Meeting | |
| Medicine, Small Group, Course Presenter, NICU Residents Morning Lectures |
Fellows supervised
| Neonata-Perinatal Medicine Fellowship, Research Advisor, 1 fellows supervised | 07/2019 - Present |
| Neonata-Perinatal Medicine Fellowship, Research Advisor, 1 fellows supervised | 12/2018 - Present |
| Neonatal-Perinatal Medicine, Research Advisor, 1 fellows supervised | 11/2017 - 06/2020 |
| Neonatal-Perinatal Medicine, Research Advisor, 1 fellows supervised | 11/2017 - 06/2019 |
| Neonatal-Perinatal Medicine, Academic Mentor, 1 fellows supervised | 01/2017 - Present |
| Neonatal_Perinatal Medicine, Research Advisor, 1 fellows supervised | 10/2015 - 06/2018 |
| Neonatal-Perinatal Medicine, Research Advisor, 1 fellows supervised | 10/2014 - 07/2017 |
| Neonatal-Perinatal Medicine, Attending Physician, 10 fellows supervised | 07/2014 - Present |
Residency Training
| Medicine-Pediatrics, Attending Physician | 2006 - Present |
| Pediatrics, Attending Physician | 2006 - Present |
| Pediatrics, Attending Physician | 2000 - 09/2003 |